
Ripra Plus 200mg/250mg Tablet
Marketer
Rowlinges Life Science
Salt Composition
Itraconazole (200mg) + Terbinafine (250mg)
Overview Ripra Plus 200mg/250mg Tablet
Combifung 200mg/250mg tablets effectively combat various fungal infections. This dual-action medication inhibits the growth and spread of infection-causing microorganisms. Combifung 200mg/250mg is available only with a doctor's prescription and should be taken precisely as directed. Administer with food at consistent intervals for optimal results. Exceeding the prescribed dosage can be detrimental. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even if symptoms improve; premature cessation may reduce effectiveness. Potential side effects include nausea, vomiting, diarrhea, and headache. Seek immediate medical attention if side effects worsen or an allergic reaction (rash, itching, swelling, breathing difficulties) occurs. Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally safe for driving, refrain from operating machinery if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration will aid recovery. Your doctor may order tests to monitor the medication's impact.
Uses of Ripra Plus 200mg/250mg Tablet
Managing fungal diseases
Major Benefits of Ripra Plus 200mg/250mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Ripra Plus 200mg/250mg Tablet with a meal.
Common Side effects of Ripra Plus 200mg/250mg Tablet:
- Headache
- Taste change
- Nausea
- Vomiting
- Diarrhea
- Upset stomach
- Loss of appetite
- Itching
- Rash
- Increased liver enzymes
How to use Ripra Plus 200mg/250mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; do not chew, crush, or divide it. Administer Ripra Plus 200mg/250mg Tablet with a meal.
How Ripra Plus 200mg/250mg Tablet works:
Itraconazole and Terbinafine, combined as Ripra Plus 200mg/250mg tablets, combat fungal skin infections. This dual-action antifungal medication works by disrupting fungal cell membranes, halting their growth and eliminating the infection.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining alcohol and Ripra Plus 200mg/250mg tablets. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Ripra Plus 200mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Ripra Plus 200mg/250mg tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Ripra Plus 200mg/250mg tablets.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Ripra Plus 200mg/250mg Tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Ripra Plus 200mg/250mg Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Ripra Plus 200mg/250mg Tablets are contraindicated in individuals with severe or active liver disease. Report any jaundice symptoms immediately to your doctor.
What if you forget to take Ripra Plus 200mg/250mg Tablet :
Should you forget a Ripra Plus 200mg/250mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ripra Plus 200mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
